Cargando…

IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic cancer has been a threateningly lethal malignant tumor worldwide. Despite the promising survival improvement in other cancer types attributing to the fast development of molecular precise medicine, the current treatment situation of pancreatic cancer is still woefully challeng...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Rong, Qi, Guoye, Zeng, Zixin, Shen, Ningning, Wang, Ziyue, Shen, Honghong, Gao, Lifang, Song, Chen, Ma, Wenxia, Wang, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613923/ https://www.ncbi.nlm.nih.gov/pubmed/34819098 http://dx.doi.org/10.1186/s12935-021-02324-w

Ejemplares similares

Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma
por: Zhang, Xiaoqin, et al.
Publicado: (2021)

Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis
por: Ma, Wenxia, et al.
Publicado: (2019)

Effect of Immortalization-Upregulated Protein-2 (IMUP-2) on Cell Death of Trophoblast
por: Jung, Ran, et al.
Publicado: (2013)

Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression
por: Wang, Ziyue, et al.
Publicado: (2023)

MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma
por: Wang, Xing, et al.
Publicado: (2020)

Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma
por: Liu, Shuli, et al.
Publicado: (2017)

Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression
por: Pan, Zongfu, et al.
Publicado: (2018)

Clinical M2 macrophages-related genes to aid therapy in pancreatic ductal adenocarcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

DNA methyltransferase 1 inhibits microRNA-497 and elevates GPRC5A expression to promote chemotherapy resistance and metastasis in breast cancer
por: Liu, Yaobang, et al.
Publicado: (2022)

SLPI knockdown induced pancreatic ductal adenocarcinoma cells proliferation and invasion
por: Zhang, Wei, et al.
Publicado: (2015)

Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma
por: Gui, Ziwei, et al.
Publicado: (2023)

Molecular profiling of gene fusions in soft tissue sarcomas by Ion AmpliSeq(TM): a study of 35 cases
por: Wei, Rong, et al.
Publicado: (2022)

GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR
por: Zhou, H, et al.
Publicado: (2016)

MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma
por: Dai, Chen, et al.
Publicado: (2020)

Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2021)

circGprc5a Promoted Bladder Oncogenesis and Metastasis through Gprc5a-Targeting Peptide
por: Gu, Chaohui, et al.
Publicado: (2018)

High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients
por: Chen, Yangshan, et al.
Publicado: (2019)

High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients
por: Lu, Siyi, et al.
Publicado: (2021)

Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse
por: Zhong, Ying, et al.
Publicado: (2013)

Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
por: Kim, Mi-Ju, et al.
Publicado: (2017)

Overexpression and Tyr421-phosphorylation of cortactin is induced by three-dimensional spheroid culturing and contributes to migration and invasion of pancreatic ductal adenocarcinoma (PDAC) cells
por: Stock, Katharina, et al.
Publicado: (2019)

Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma
por: Cai, Weiyang, et al.
Publicado: (2021)

LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway
por: Wu, Liping, et al.
Publicado: (2020)

GPRC5A: An Emerging Biomarker in Human Cancer
por: Jiang, Xiaoxia, et al.
Publicado: (2018)

Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling
por: Kuo, Sung-Hsin, et al.
Publicado: (2021)

Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation
por: Deng, Huan, et al.
Publicado: (2021)

Impaired Osteoblast Function in GPRC6A Null Mice
por: Pi, Min, et al.
Publicado: (2010)

Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma
por: Liu, Jiahua, et al.
Publicado: (2021)

The emerging roles of GPRC5A in diseases
por: Zhou, Honglei, et al.
Publicado: (2014)

Characterization of ductal carcinoma in situ cell lines established from breast tumor of a Singapore Chinese patient
por: Yong, Jacklyn WY, et al.
Publicado: (2014)

Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma
por: Zhu, Lei, et al.
Publicado: (2021)

AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma
por: Feng, Ziyang, et al.
Publicado: (2022)

Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study
por: Zhang, Yuchao, et al.
Publicado: (2020)

Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma
por: Li, Juan, et al.
Publicado: (2015)

Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease
por: Kruger, Deirdré, et al.
Publicado: (2022)

Computationally identified novel agonists for GPRC6A
por: Pi, Min, et al.
Publicado: (2018)

GPRC5B protects osteoarthritis by regulation of autophagy signaling
por: He, Liang, et al.
Publicado: (2023)

The interplay between ATF2 and NEAT1 contributes to lung adenocarcinoma progression
por: Liu, Jian, et al.
Publicado: (2020)

Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma
por: Ma, Jiayu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_unr8dvicc927a84fnbq28v29ki